{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:22:05Z","timestamp":1791638525075,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1124\/jpet.113.208538","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T03:38:34Z","timestamp":1383709114000},"page":"106-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pharmacological Characterization of a Dopamine Transporter Ligand That Functions as a Cocaine Antagonist"],"prefix":"10.1016","volume":"348","author":[{"given":"Rajeev I.","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Grandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl R.","family":"Lupica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.113.208538_bib1","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1021\/jm970525a","article-title":"Novel N-substituted 3 alpha-[bis(4\u2032-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter","volume":"40","author":"Agoston","year":"1997","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.113.208538_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1124\/jpet.105.090829","article-title":"Assessment of the influence of histaminergic actions on cocaine-like effects of 3alpha-diphenylmethoxytropane analogs","volume":"315","author":"Campbell","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.208538_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00213-002-1142-y","article-title":"Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice","volume":"163","author":"Chausmer","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.208538_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-002-1319-4","article-title":"Evidence of cross-tolerance between behavioural effects of nicotine and cocaine in mice","volume":"166","author":"Desai","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.208538_bib5","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1523\/JNEUROSCI.4778-04.2005","article-title":"Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine","volume":"25","author":"Desai","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.113.208538_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.105.091231","article-title":"Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-2-[bis-(4-fluorophenyl)methoxy]ethyl-4-(3-phenylpropyl)piperazine], and benztropine analogs","volume":"315","author":"Desai","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.208538_bib7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.108.145813","article-title":"Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors","volume":"329","author":"Hiranita","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.208538_bib8","doi-asserted-by":"crossref","unstructured":"Hiranita T, Kohut SJ, Soto PL, Tanda G, Kopajtic TA, Katz JL (2013) Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-administration in rats. J Pharmacol Exp Ther doi: 10.1124\/jpet.113.208264 [Epub Ahead of Print].","DOI":"10.1124\/jpet.113.208264"},{"key":"10.1124\/jpet.113.208538_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/jpet.103.061242","article-title":"Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats","volume":"309","author":"Jutkiewicz","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.208538_bib10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0022-3565(24)37956-X","article-title":"Novel 3\u03b1-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine","volume":"288","author":"Katz","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.208538_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1124\/jpet.103.060525","article-title":"Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands","volume":"309","author":"Katz","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.208538_bib12","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3390\/ph4060880","article-title":"A role for sigma receptors in stimulant self administration and addiction","volume":"4","author":"Katz","year":"2011","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1124\/jpet.113.208538_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.110.171629","article-title":"Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability","volume":"335","author":"Kopajtic","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.208538_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0969-8051(95)02074-8","article-title":"Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3 \u03b2-(4-[125I]iodophenyl) tropan-2 \u03b2-carboxylic acid isopropyl ester ([125I]RTI-121)","volume":"23","author":"Lever","year":"1996","journal-title":"Nucl Med Biol"},{"key":"10.1124\/jpet.113.208538_bib15","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/jpet.105.084541","article-title":"Place conditioning and locomotor effects of N-substituted, 4\u2032,4\u2033-difluorobenztropine analogs in rats","volume":"313","author":"Li","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.208538_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1124\/jpet.110.173260","article-title":"N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects","volume":"336","author":"Li","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.208538_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00213-012-2862-2","article-title":"The stereotypy-inducing effects of N-substituted benztropine analogs alone and in combination with cocaine do not account for their blockade of cocaine self-administration","volume":"225","author":"Li","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.208538_bib18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1124\/mol.107.039800","article-title":"Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors","volume":"73","author":"Loland","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.113.208538_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1586\/ecp.09.18","article-title":"Targeting sigma receptors: novel medication development for drug abuse and addiction","volume":"2","author":"Matsumoto","year":"2009","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1124\/jpet.113.208538_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","article-title":"Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures","volume":"14","author":"Mello","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.113.208538_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(91)90355-T","article-title":"Selective sigma ligands block stimulant effects of cocaine","volume":"201","author":"Menkel","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.208538_bib22","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1476-5381.2009.00124.x","article-title":"Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter","volume":"156","author":"Navarro","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.208538_bib23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.103.053504","article-title":"Evaluation of the blood-brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques","volume":"307","author":"Raje","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.208538_bib24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/syn.890040415","article-title":"Cocaine receptors: in vivo labeling with 3H-(-)cocaine, 3H-WIN 35,065-2, and 3H-WIN 35,428","volume":"4","author":"Scheffel","year":"1989","journal-title":"Synapse"},{"key":"10.1124\/jpet.113.208538_bib25","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0022-3565(25)24798-X","article-title":"In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428","volume":"257","author":"Scheffel","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.208538_bib26","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00001756-199211000-00005","article-title":"Dopamine transporter imaging with novel, selective cocaine analogs","volume":"3","author":"Scheffel","year":"1992","journal-title":"Neuroreport"},{"key":"10.1124\/jpet.113.208538_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1471-4159.2008.05361.x","article-title":"Cocaine-like neurochemical effects of antihistaminic medications","volume":"106","author":"Tanda","year":"2008","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.113.208538_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1054-3589(08)57007-4","article-title":"Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors","volume":"57","author":"Tanda","year":"2009","journal-title":"Adv Pharmacol"},{"key":"10.1124\/jpet.113.208538_bib29","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/jpet.109.154302","article-title":"Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity","volume":"330","author":"Tanda","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.208538_bib30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00213-013-3109-6","article-title":"Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change","volume":"229","author":"Tanda","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.208538_bib31","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1038\/npp.2009.78","article-title":"The dopamine uptake inhibitor 3 alpha-[bis(4\u2032-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward","volume":"34","author":"Vel\u00e1zquez-S\u00e1nchez","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.113.208538_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.euroneuro.2010.03.005","article-title":"The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization","volume":"20","author":"Vel\u00e1zquez-S\u00e1nchez","year":"2010","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/jpet.113.208538_bib33","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1176\/appi.ajp.162.8.1432","article-title":"Medication development for addictive disorders: the state of the science","volume":"162","author":"Vocci","year":"2005","journal-title":"Am J Psychiatry"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524271846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524271846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.208538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:09:15Z","timestamp":1739995755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524271846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0022356524271846"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.208538","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Characterization of a Dopamine Transporter Ligand That Functions as a Cocaine Antagonist","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.208538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}